Shaoting Zhang

Shaoting Zhang

Auto-generated profile, based on publicly available information

Shaoting Zhang

SenseTime Research, Shanghai, China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2022 in Medical Image Analysis
Verified
Journal Article
Closed access
XLXiangde Luo
Xiangde Luo
GWGuotai Wang
Guotai Wang
WLWenjun Liao
Wenjun Liao
JCJieneng Chen
Jieneng Chen
TSTao Song
Tao Song
SZShaoting Zhang
Shaoting Zhang

12 October 2023 in Medical Image Analysis
Verified
Journal Article
Closed access
SZShaoting Zhang
Shaoting Zhang
DMDimitris Metaxas
Dimitris Metaxas

24 May 2022 in Medical Image Analysis
Verified
Journal Article
Closed access
QDQian Da
Qian Da
XHXiaodi Huang
Xiaodi Huang
ZLZhongyu Li
Zhongyu Li
YZYanfei Zuo
Yanfei Zuo
CZChenbin Zhang
Chenbin Zhang
SZShaoting Zhang
Shaoting Zhang

20 January 2025 in IEEE Reviews in Biomedical Engineering
Verified
Journal Article
Closed access
WKWasif Khan
Wasif Khan
SLSeowung Leem
Seowung Leem
KSKyle B. See
Kyle B. See
JWJoshua Wong
Joshua Wong
SZShaoting Zhang
Shaoting Zhang
RFRuogu Fang
Ruogu Fang
Foundation models (FMs) are large-scale deeplearning models that are developed using large datasets and self-supervised learning methods. These models serve as a base for different downstream tasks, including healthcare. FMs have been adopted with great success across various domains within healthcare. Existing healthcare-based surveys have not yet included all of these domains. Therefore, we provide a detailed survey of FMs in healthcare. We focus on the history, learning strategies, flagship models, applications, and challenges of FMs. We explore how FMs such as the BERT and GPT families are reshaping various healthcare domains, including clinical large language models, medical image analysis, and omics. Furthermore, we provide a detailed taxonomy of healthcare applications facilitated by FMs, such as clinical NLP, medical computer vision, graph learning, and other biology-related tasks. Despite the promising opportunities FMs provide, they also have several associated challenges, which are explained in detail. We also outline open research issues and potential lessons learned to provide researchers and practitioners with insights into the capabilities of FMs in healthcare to advance their deployment and mitigate associated risks.

23 September 2021 in npj Precision Oncology
Verified
Journal Article
Open access
PDF file
HQHui Qu
Hui Qu
MZMu Zhou
Mu Zhou
ZYZhennan Yan
Zhennan Yan
HWHe Wang
He Wang
VRVinod Rustgi
Vinod Rustgi
DMDimitris N. Metaxas
Dimitris N. Metaxas
Breast carcinoma is the most common cancer among women worldwide that consists of a heterogeneous group of subtype diseases. The whole-slide images (WSIs) can capture the cell-level heterogeneity, and are routinely used for cancer diagnosis by pathologists. However, key driver genetic mutations related to targeted therapies are identified by genomic analysis like high-throughput molecular profiling. In this study, we develop a deep-learning model to predict the genetic mutations and biological pathway activities directly from WSIs. Our study offers unique insights into WSI visual interactions between mutation and its related pathway, enabling a head-to-head comparison to reinforce our major findings. Using the histopathology images from the Genomic Data Commons Database, our model can predict the point mutations of six important genes (AUC 0.68–0.85) and copy number alteration of another six genes (AUC 0.69–0.79). Additionally, the trained models can predict the activities of three out of ten canonical pathways (AUC 0.65–0.79). Next, we visualized the weight maps of tumor tiles in WSI to understand the decision-making process of deep-learning models via a self-attention mechanism. We further validated our models on liver and lung cancers that are related to metastatic breast cancer. Our results provide insights into the association between pathological image features, molecular outcomes, and targeted therapies for breast cancer patients.

15 October 2024 in Medical Image Analysis
Verified
Journal Article
Closed access
WLWenhui Lei
Wenhui Lei
WXWei Xu
Wei Xu
KLKang Li
Kang Li
XZXiaofan Zhang
Xiaofan Zhang
SZShaoting Zhang
Shaoting Zhang